Navigation Links
The first International Sigma Anti-Bonding Calcium Symposium (ISACS 2019) by CBHI
Date:10/10/2019

Calcium & Bone Health Institute (CBHI) held International Sigma Anti-Bonding Calcium Symposium (ISACS) 2019 at Executive Plaza Hotel in Vancouver, Canada on September 23-24 for two days. The purpose of symposium was to discuss and share the knowledge of the various measures to develop healthy bone and to prevent calcium-related diseases. The theme of this year was “The Secret of Reversible Bone Health”.

“While serving as the president of CBHI which conducts intensive research about the significance of calcium for the human body, I thought of a place where researchers and professors come together to share their knowledge and create synergy effect in their research field,” said Dr. Paul Lee, the ISACS Chair. “I am very grateful that we could start the first Symposium in Vancouver, Canada. I hope more people be aware of the importance of bone health and the available solutions for their bodies.”

The speakers included researchers, professors, dentists, pharmacists, businessmen and patients. People from U.S.A., Canada, Korea, China, Indonesia, and Japan attended in the event. The topics by speakers ranged from cancer, bone, dental treatment, and arrhythmias, to diabetes. Testimonials by patients with SAC treatment were also presented.

SAC (Sigma Anti-Bonding Calcium) calcium was invented by Dr. Paul Lee in 2009. The atomic orbitals of SAC calcium molecule have sigma anti-bonding and therefore, easily separated into atoms in the water, absorbed in the body in the ionic form, Ca++. It is 200 times more soluble in water and has shown up to 80% bone mineral density increase in thousands of people. SAC calcium awakens body’s dormant response and the process is fully natural without side effect.

As the first ISACS 2019 was successfully held, CBHI plans to hold the event internationally following years.

About CBHI
Calcium and Bone Health Institute (CBHI) is Canada based research organization that has invented Sigma Anti-bonding Calcium (SAC). It has partnership with many universities and research organizations. Its invented SAC calcium was tried by thousands of people with great responses from their bodies. It continues to research on many challenging diseases such as osteoporosis, cancer, stem cell, diabetes, Alzheimer’s disease and more.

Read the full story at https://www.prweb.com/releases/the_first_international_sigma_anti_bonding_calcium_symposium_isacs_2019_by_cbhi/prweb16627357.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Aware, Inc. Reports First Quarter 2013 Financial Results
2. Odd experiments by Americas first physiologist shed light on digestion
3. CNIO researchers capture the replication of the human genome for the first time
4. European support for the first network of research and training in political ecology
5. Bowman Design Group is first US company awarded German FAMAB Sustainable Company certification
6. First Atlanta Science Festival set for 2014
7. Gym class reduces probability of obesity, study finds for first time
8. First successful treatment of pediatric cerebral palsy with autologous cord blood
9. Emory, Georgia Tech receive first human exposome center grant in US
10. Thermal limit for animal life redefined by first lab study of deep-sea vent worms
11. First dual-action compound kills cancer cells, stops them from spreading
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2020)... ... 24, 2020 , ... The Rockies Venture Club and Colorado ... early-stage bioscience companies in the state. , “Colorado has a world-class ... they need to innovate and grow. This program will mobilize capital within ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... Advanced Regenerative Manufacturing Institute (ARMI). Headquartered in Manchester, New Hampshire, ARMI is ... 100 partner organizations from industry, government, academia and the non-profit sector to ...
(Date:1/10/2020)... N.C. (PRWEB) , ... January 09, 2020 , ... ... commercialization of bioactive spinal solutions, today announced the 510(K) clearance and commercial launch ... direct lateral interbody fusion system. , The EVOL®ha-DLIF is made of PEEK-OPTIMA ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... , ... February 19, 2020 , ... ... solutions for the life sciences industry, today announced the opening of a new ... Associate Partner, Red Nucleus R&D. , Red Nucleus announced the new office in ...
(Date:2/5/2020)... FARMINGTON, Conn. (PRWEB) , ... February 04, 2020 ... ... that develops tools for characterizing microbiome populations down to the strain level, has ... Limited, will sell Shoreline Biome’s microbiome kits and other products to companies and ...
(Date:1/28/2020)... ... January 28, 2020 , ... ... biopharmaceutical R&D, today announced the release of Genedata Expressionist ® 13.5 ... the implementation of Multi-Attribute Methods (MAM) for characterizing and monitoring the quality ...
(Date:1/24/2020)... ... January 24, 2020 , ... The impact of new ... therapeutics, laboratory and clinical services during the first two decades of the 21st ... as Slone Partners celebrates its 20th anniversary this year, its evolution ...
Breaking Biology Technology: